Multicenter phase II trial of florbetaben beta-amyloid PET imaging in Alzheimer's disease: Results in a close to clinically routine situation
Alzheimer's & Dementia（2013）
Abstract
P1-299 MULTICENTER PHASE II TRIAL OF FLORBETABEN BETA-AMYLOID PET IMAGING IN ALZHEIMER’S DISEASE: RESULTS IN ACLOSE TO CLINICALLY ROUTINE SITUATION Osama Sabri, John Seibyl, Keiichi Ischihara, Amane Tateno, Alexander Drzezga, Timo Grimmer, Michio Senda, Yasuji Yamamoto, Hermann-Josef Gertz, Cornelia Reininger, Henryk Barthel, University of Leipzig, Leipzig, Germany; Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States; Nippon Medical School, Tokyo, Japan; University of Cologne, Cologne, Germany; TU Munich, Munich, Germany; J-ADNI PET Core, Kobe, Japan; Kobe University Hospital, Kobe, Japan; Bayer Healthcare, Berlin, Germany; University of Leipzig, Leipzig, Germany. Contact e-mail: Osama.Sabri@medizin.uni-leipzig.de
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined